Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Balance Sheet Analysis Highlights
Borrowings
YoY Growth in year ended Mar 2025 is 79.31% vs -67.42% in Mar 2024
Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods;
Fixed Assets
YoY Growth in year ended Mar 2025 is 66.48% vs 93.51% in Mar 2024
Investments
No Investments in the last few periods;
Current Assets
YoY Growth in year ended Mar 2025 is 11.98% vs 58.76% in Mar 2024
Compare Balance Sheet Results of Shelter Pharma
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
11.56
18.13
-6.57
-36.24%
Share Warrants & Outstandings
Total Reserve
31.16
37.49
-6.33
-16.88%
Shareholder's Funds
42.72
55.62
-12.90
-23.19%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
0.93
6.76
-5.83
-86.24%
Secured Loans
0.00
5.49
-5.49
-100.00%
Unsecured Loans
0.93
1.27
-0.34
-26.77%
Deferred Tax Assets / Liabilities
-0.03
3.14
-3.17
-100.96%
Other Long Term Liabilities
0.05
0.00
0.05
0.00%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
0.00
0.00
0.00
0.00%
Total Non-Current Liabilities
0.95
9.90
-8.95
-90.40%
Current Liabilities
Trade Payables
1.25
16.73
-15.48
-92.53%
Other Current Liabilities
3.27
3.30
-0.03
-0.91%
Short Term Borrowings
0.11
5.70
-5.59
-98.07%
Short Term Provisions
0.00
0.00
0.00
0.00%
Total Current Liabilities
4.63
25.73
-21.10
-82.01%
Total Liabilities
48.30
91.25
-42.95
-47.07%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
8.36
40.90
-32.54
-79.56%
Less: Accumulated Depreciation
2.39
0.00
2.39
0.00%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
5.96
40.90
-34.94
-85.43%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
0.00
0.00
0.00
0.00%
Intangible assets under development
0.00
0.00
0.00
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
0.68
0.00
0.68
0.00%
Long Term Loans & Advances
8.39
0.00
8.39
0.00%
Other Non Current Assets
0.00
1.16
-1.16
-100.00%
Total Non-Current Assets
15.03
42.06
-27.03
-64.27%
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00%
Inventories
12.90
16.10
-3.20
-19.88%
Sundry Debtors
9.47
20.23
-10.76
-53.19%
Cash and Bank
3.42
8.61
-5.19
-60.28%
Other Current Assets
1.77
4.07
-2.30
-56.51%
Short Term Loans and Advances
5.72
0.17
5.55
3,264.71%
Total Current Assets
33.28
49.19
-15.91
-32.34%
Net Current Assets (Including Current Investments)
28.65
23.46
5.19
22.12%
Total Current Assets Excluding Current Investments
33.28
49.19
-15.91
-32.34%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
48.30
91.25
-42.95
-47.07%
Contingent Liabilities
0.00
0.00
0.00
0.00%
Total Debt
1.04
12.46
-11.42
-91.65%
Book Value per share (adjusted)
36.14
30.68
5.46
17.80%
Annual - Borrowings
Borrowings 1.04 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 79.31% vs -67.42% in Mar 2024
Annual - Other Long Term Liabilities
Other Long Term Liabilities 0.05 Cr
in Mar 2025Figures in Cr
No Other Long Term Liabilities in the last few periods;
Annual - Fixed Assets
Fixed Assets 5.96 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 66.48% vs 93.51% in Mar 2024
Annual - Investments
Investments 0.68 Cr
in Mar 2025Figures in Cr
No Investments in the last few periods;
Annual - Current Assets
Current Assets 33.28 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 11.98% vs 58.76% in Mar 2024






